123 related articles for article (PubMed ID: 19935077)
1. Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition.
Kang BY; Khan JA; Ryu S; Shekhar R; Seung KB; Mehta JL
J Cardiovasc Pharmacol; 2010 Feb; 55(2):176-83. PubMed ID: 19935077
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
Kang BY; Mehta JL
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024
[TBL] [Abstract][Full Text] [Related]
3. Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition.
Kang BY; Khan JA; Ryu S; Shekhar R; Seung KB; Mehta JL
J Cardiovasc Pharmacol; 2010 Apr; 55(4):417-24. PubMed ID: 20422739
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA.
Wang X; Khaidakov M; Ding Z; Mitra S; Lu J; Liu S; Mehta JL
Exp Biol Med (Maywood); 2012 Dec; 237(12):1394-401. PubMed ID: 23354398
[TBL] [Abstract][Full Text] [Related]
5. Genomics of cardiac remodeling in angiotensin II-treated wild-type and LOX-1-deficient mice.
Kang BY; Hu C; Ryu S; Khan JA; Biancolella M; Prayaga S; Seung KB; Novelli G; Mehta P; Mehta JL
Physiol Genomics; 2010 Jun; 42(1):42-54. PubMed ID: 20332185
[TBL] [Abstract][Full Text] [Related]
6. Cardiac hypertrophy during hypercholesterolemia and its amelioration with rosuvastatin and amlodipine.
Kang BY; Wang W; Palade P; Sharma SG; Mehta JL
J Cardiovasc Pharmacol; 2009 Oct; 54(4):327-34. PubMed ID: 19687748
[TBL] [Abstract][Full Text] [Related]
7. LOX-1 dependent overexpression of immunoglobulins in cardiomyocytes in response to angiotensin II.
Kang BY; Hu C; Prayaga S; Khaidakov M; Sawamura T; Seung KB; Mehta JL
Biochem Biophys Res Commun; 2009 Feb; 379(2):395-9. PubMed ID: 19126408
[TBL] [Abstract][Full Text] [Related]
8. Delineation of the effects of angiotensin type 1 and 2 receptors on HL-1 cardiomyocyte apoptosis.
Wang X; Lu J; Khaidakov M; Mitra S; Ding Z; Goyal T; Mehta JL
Apoptosis; 2012 Aug; 17(8):908-15. PubMed ID: 22527949
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II induces capillary formation from endothelial cells via the LOX-1 dependent redox-sensitive pathway.
Hu C; Dandapat A; Mehta JL
Hypertension; 2007 Nov; 50(5):952-7. PubMed ID: 17893372
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation.
Mehta JL; Hu B; Chen J; Li D
Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2203-8. PubMed ID: 12958047
[TBL] [Abstract][Full Text] [Related]
11. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.
Hingtgen SD; Tian X; Yang J; Dunlay SM; Peek AS; Wu Y; Sharma RV; Engelhardt JF; Davisson RL
Physiol Genomics; 2006 Aug; 26(3):180-91. PubMed ID: 16670255
[TBL] [Abstract][Full Text] [Related]
12. Aspirin suppresses cardiac fibroblast proliferation and collagen formation through downregulation of angiotensin type 1 receptor transcription.
Wang X; Lu J; Khaidakov M; Mitra S; Ding Z; Raina S; Goyal T; Mehta JL
Toxicol Appl Pharmacol; 2012 Mar; 259(3):346-54. PubMed ID: 22306536
[TBL] [Abstract][Full Text] [Related]
13. Molecular dissection of angiotensin II-activated human LOX-1 promoter.
Chen J; Liu Y; Liu H; Hermonat PL; Mehta JL
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1163-8. PubMed ID: 16484599
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
16. Aspirin downregulates angiotensin type 1 receptor transcription implications in capillary formation from endothelial cells.
Mitra S; Wang X; Khaidakov M; Ding Z; Ayyadevera S; Hearnsberger E; Goyal T; Mehta JL
J Cardiovasc Pharmacol; 2012 Aug; 60(2):187-92. PubMed ID: 22561363
[TBL] [Abstract][Full Text] [Related]
17. The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy.
Tanaka Y; Tamura K; Koide Y; Sakai M; Tsurumi Y; Noda Y; Umemura M; Ishigami T; Uchino K; Kimura K; Horiuchi M; Umemura S
FEBS Lett; 2005 Mar; 579(7):1579-86. PubMed ID: 15757644
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation.
Li DY; Zhang YC; Philips MI; Sawamura T; Mehta JL
Circ Res; 1999 May; 84(9):1043-9. PubMed ID: 10325241
[TBL] [Abstract][Full Text] [Related]
19. Synergism of simvastatin with losartan prevents angiotensin II-induced cardiomyocyte apoptosis in vitro.
Xu J; Lü XW; Huang Y; Zhu PL; Li J
J Pharm Pharmacol; 2009 Apr; 61(4):503-10. PubMed ID: 19298698
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin preconditioning of the heart: evidence for redox signaling.
Das S; Engelman RM; Maulik N; Das DK
Cell Biochem Biophys; 2006; 44(1):103-10. PubMed ID: 16456238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
